Nanobiotix S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Nanobiotix S.A. covers the reporting period of May 2025, with the specific disclosure date of May 27, 2025. The filing serves as a notification of transactions by Persons Discharging Managerial Responsibilities (PDMR) and persons closely associated with them, submitted in compliance with the EU Market Abuse Regulation (MAR).
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a regulatory disclosure regarding insider transactions and does not contain financial performance data.
Material Changes
No material changes to financial performance or business operations are reported in this document. The filing focuses solely on the disclosure of PDMR transactions as required by MAR.
Guidance, Outlook, and Risks
The document contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is a procedural filing to satisfy transparency requirements under the EU Market Abuse Regulation.
Key Facts for Investors
- The filing discloses transactions by company insiders (PDMR) and their associates as of May 27, 2025.
- Details of the specific transactions are contained in Exhibit 99.1, which is a translation of the French version filed with the EU regulator.
- No financial results or operational updates are included in this specific Form 6-K.
- The report was signed by Bart Van Rhijn, Chief Financial and Business Officer.